About Us
WhiteLab Genomics is a TechBio company at the forefront of artificial intelligence applied to genomic medicine. Founded in 2019 and backed by Y Combinator and French Tech 2030, the company aims to accelerate the discovery and development of life-saving gene and cell therapies. Through its proprietary AI-driven platform, WhiteLab analyzes complex biological data and runs in silico simulations to design optimized therapies, reducing development timelines, costs and risks for pharmaceutical and biotech partners worldwide.
With offices in Paris and Boston, WhiteLab collaborates closely with leading pharmaceutical companies, academic institutions and innovative biotech startups, striving to be the trusted partner of choice in the genomic medicine ecosystem.
In October 2026, WhiteLab Genomics announced a $26 million Series B financing to accelerate its next phase of growth. Building on its AI-driven platform, the company is expanding its focus on the development and validation of proprietary biological assets, including next-generation delivery vectors and programmable payloads, while strengthening its international presence.
Join us – together, we’ll bring life-saving treatments to the people who need them most.
About the Role
At WhiteLab Genomics, you will work at the intersection of finance, corporate strategy and genomic medicine, and contribute to strategic projects supporting the company's growth and development.
As part of this growth, the CFO & Corporate Development function is looking for a Strategic Finance & Corporate Development Intern or Apprentice, starting in March or July 2027. The position is open to candidates seeking either a six-month end-of-study internship or an apprenticeship.
What you will Do
You will work within the CFO & Corporate Development function, with direct exposure to the Chief Financial Officer and the broader leadership team, across four areas:
Corporate Strategy & Market Intelligence: Conduct market research and competitive analysis across cell and gene therapy and AI-driven drug design; assess WhiteLab's competitive positioning; analyze the business models and value-creation levers of WhiteLab and its peers; and identify strategic opportunities and potential partners.
Financial Planning, Analysis & Valuation: Support the development and regular update of the multi-year business plan, translating operating assumptions into financial forecasts; contribute to budgeting, forecasting, financial performance and variance analysis; identify and track key operating drivers; build and maintain financial models, including scenario and sensitivity analyses; and assist with asset and company valuation to support investment decisions.
Corporate Development, Financing & Transactions: Analyze the economics of strategic partnerships, licensing deals and other strategic transactions; support due diligence and transaction analysis for partnerships and M&A opportunities; and contribute to the preparation of future financing rounds, including investor analysis and deal materials.
Strategic Projects & Executive Materials: Contribute to selected cross-functional strategic projects with the Business Development, scientific, product and platform, and Data Science teams; and help prepare Board materials and presentations for senior stakeholders, turning quantitative and qualitative data into clear, actionable insights.